New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
15:21 EDTPRKR, GLPW, FF, DTSI, KYTH, GALENotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Kythera Biopharmaceuticals (KYTH), consensus (69c); FutureFuel (FF), consensus 23c; Parkervision (PRKR), one estimate (6c); DTS Inc. (DTSI), consensus 49c; Global Power Equipment (GLPW), consensus 37c; Galena Biopharma (GALE), consensus (9c)
News For KYTH;FF;PRKR;DTSI;GLPW;GALE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
08:24 EDTGLPWGlobal Power update represents loss of $70M in revenue, says William Blair
Subscribe for More Information
08:21 EDTGLPWGlobal Power Equipment announces termination of contract with Southern Company
Subscribe for More Information
August 25, 2015
10:10 EDTKYTHHigh option volume stocks
Subscribe for More Information
08:37 EDTGLPWGlobal Power Equipment awarded $565M contract extension
Subscribe for More Information
August 24, 2015
07:07 EDTGALEIDMC recommends reduction of cardiac toxicity monitoring in Galena NeuVax trial
Galena Biopharma announced that the Independent Data Monitoring Committee, or IDMC, has recommended to the company that it can reduce the cardiac toxicity monitoring for patients in its NeuVax Phase 3 Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, or PRESENT, clinical trial. The trial is being run under a Special Protocol Assessment, or SPA, approved by the FDA. Following its most recent IDMC meeting in June, the IDMC recommended routine cardiac monitoring could be reduced in the PRESENT trial and that such a reduction is justified and consistent with the pre-specified Cardiac Toxicity Monitoring Stopping Rules defined in the study protocol. The IDMC concluded that cardiac toxicity monitoring by echocardiogram, or ECHO, or multiple-gated acquisition, or MUGA, scans could be reduced. The IDMC had no other suggestions and recommended the trial continue as planned.
August 20, 2015
16:20 EDTKYTHGabelli reports 5.55% stake in KYTHERA
August 18, 2015
09:04 EDTKYTHKYTHERA submits MMA in EU for ATX-101
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use